Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Mid and small caps lead the gains
Wed, 6 Aug 11:30 am

After opening weak, the benchmark Indian indices have remained below the dotted line in the morning session amid outperformance among mid and small cap stocks. Banking stocks have borne the brunt of the selling pressure while engineering stocks are leading the gainers.

The BSE-Sensex is trading down 23 points. The NSE-Nifty is trading down 10 points. The BSE Mid Cap index is trading up 0.3% and the BSE Small Cap index is trading up 0.8%. The rupee is trading at 61.33 to the US dollar.

Software stocks are trading on a mixed note. While Infosys is leading the gainers; Tata Consultancy Services (TCS) is among the leading losers. India's fifth largest software firm Tech Mahindra, has announced an expansion of its European operations. The company plans to set up a new center in Hungary. This center will employ about 200 people and will provide a boost to its operations in Eastern Europe. The company derives about 31% of its revenues for Europe but most of it comes from the advanced economies of Western Europe. This new facility will come up in the capital city of Budapest. Tech Mahindra has already hired 50 people to be staffed at this center and will sale up its operations soon. Tech Mahindra is trading flat today.

Majority of Indian pharma stocks are trading in green with JB chemicals and Dishman pharma being among the leading gainers. Ajanta pharma has declared June quarter 2014 results (1QFY15). Revenue from operations grew by 32% YoY during the quarter. Company witnessed robust growth in both domestic and international businesses. The operating margins also witnessed sharp improvement of approx 800 bps, leading to EBITDA growth of 78% YoY. The profit after tax has also increased by 80% YoY for the quarter. Ajanta is trading up 0.56% YoY.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Mid and small caps lead the gains". Click here!


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Mar 22, 2018 (Close)